Profile | GDS5420 / 211356_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 33.5 | 25 |
GSM1296119 | B_lesional_pre-dose | 158.18 | 48 |
GSM1296076 | C_lesional_pre-dose | 89.93 | 41 |
GSM1296092 | D_lesional_pre-dose | 70.71 | 38 |
GSM1296103 | E_lesional_pre-dose | 23.27 | 21 |
GSM1296078 | F_lesional_pre-dose | 80.51 | 39 |
GSM1296107 | G_lesional_pre-dose | 184.69 | 50 |
GSM1296109 | H_lesional_pre-dose | 90.25 | 38 |
GSM1296080 | I_lesional_pre-dose | 60.29 | 35 |
GSM1296090 | J_lesional_pre-dose | 71.22 | 37 |
GSM1296074 | K_lesional_pre-dose | 28.16 | 24 |
GSM1296111 | L_lesional_pre-dose | 106.74 | 40 |
GSM1296099 | M_lesional_pre-dose | 65.71 | 35 |
GSM1296086 | O_lesional_pre-dose | 50.07 | 32 |
GSM1296117 | P_lesional_pre-dose | 148.47 | 46 |
GSM1296113 | Q_lesional_pre-dose | 329.83 | 60 |
GSM1296096 | R_lesional_pre-dose | 44.21 | 30 |
GSM1296105 | S_lesional_pre-dose | 66.93 | 34 |
GSM1296098 | T_lesional_pre-dose | 57.19 | 31 |
GSM1296101 | U_lesional_pre-dose | 16.22 | 15 |
GSM1296121 | V_lesional_pre-dose | 86.55 | 38 |
GSM1296088 | W_lesional_pre-dose | 46.84 | 31 |
GSM1296082 | X_lesional_pre-dose | 106.19 | 44 |
GSM1296115 | Y_lesional_pre-dose | 177.19 | 50 |
GSM1296084 | Z_lesional_pre-dose | 33.12 | 24 |
GSM1296072 | B_lesional_day8 | 108.84 | 41 |
GSM1296069 | L_lesional_day8 | 84.75 | 35 |
GSM1296071 | P_lesional_day8 | 242.51 | 54 |
GSM1296070 | Y_lesional_day8 | 284.26 | 57 |
GSM1296073 | V_lesional_day8 | 75.66 | 36 |
GSM1296034 | A_lesional_day15 | 69.84 | 35 |
GSM1296041 | G_lesional_day15 | 105.72 | 41 |
GSM1296035 | R_lesional_day15 | 34.12 | 27 |
GSM1296038 | U_lesional_day15 | 37.84 | 27 |
GSM1296047 | B_lesional_day15 | 62.48 | 31 |
GSM1296039 | E_lesional_day15 | 71.95 | 37 |
GSM1296042 | H_lesional_day15 | 191.02 | 50 |
GSM1296043 | L_lesional_day15 | 84.99 | 36 |
GSM1296037 | M_lesional_day15 | 55.08 | 31 |
GSM1296046 | P_lesional_day15 | 257.93 | 55 |
GSM1296044 | Q_lesional_day15 | 398.12 | 63 |
GSM1296045 | Y_lesional_day15 | 286.75 | 57 |
GSM1296025 | C_lesional_day15 | 101.49 | 42 |
GSM1296033 | D_lesional_day15 | 76.64 | 38 |
GSM1296027 | I_lesional_day15 | 107.61 | 45 |
GSM1296032 | J_lesional_day15 | 133.96 | 46 |
GSM1296024 | K_lesional_day15 | 62.85 | 35 |
GSM1296031 | W_lesional_day15 | 113.31 | 42 |
GSM1296028 | X_lesional_day15 | 90.29 | 40 |
GSM1296029 | Z_lesional_day15 | 52.79 | 32 |
GSM1296026 | F_lesional_day15 | 83.61 | 39 |
GSM1296030 | O_lesional_day15 | 18.71 | 20 |
GSM1296040 | S_lesional_day15 | 6.55 | 6 |
GSM1296036 | T_lesional_day15 | 51.77 | 30 |
GSM1296048 | V_lesional_day15 | 65.26 | 33 |
GSM1296059 | A_lesional_day43 | 53.48 | 33 |
GSM1296066 | G_lesional_day43 | 185.45 | 50 |
GSM1296060 | R_lesional_day43 | 36.45 | 27 |
GSM1296063 | U_lesional_day43 | 81.71 | 38 |
GSM1296064 | E_lesional_day43 | 67.27 | 36 |
GSM1296067 | H_lesional_day43 | 136.87 | 44 |
GSM1296062 | M_lesional_day43 | 55.37 | 33 |
GSM1296068 | Q_lesional_day43 | 339.25 | 60 |
GSM1296050 | C_lesional_day43 | 162.78 | 49 |
GSM1296057 | D_lesional_day43 | 74.97 | 37 |
GSM1296052 | I_lesional_day43 | 138.65 | 48 |
GSM1296054 | J_lesional_day43 | 72.24 | 36 |
GSM1296049 | K_lesional_day43 | 80.96 | 38 |
GSM1296055 | W_lesional_day43 | 71.36 | 35 |
GSM1296053 | X_lesional_day43 | 68.26 | 36 |
GSM1296058 | Z_lesional_day43 | 60.72 | 35 |
GSM1296051 | F_lesional_day43 | 65.22 | 35 |
GSM1296056 | O_lesional_day43 | 19.87 | 19 |
GSM1296065 | S_lesional_day43 | 64.57 | 34 |
GSM1296061 | T_lesional_day43 | 90.9 | 39 |
GSM1296095 | A_non-lesional_pre-dose | 119.55 | 45 |
GSM1296120 | B_non-lesional_pre-dose | 133.5 | 44 |
GSM1296077 | C_non-lesional_pre-dose | 138.14 | 47 |
GSM1296093 | D_non-lesional_pre-dose | 50.44 | 30 |
GSM1296104 | E_non-lesional_pre-dose | 74.74 | 37 |
GSM1296079 | F_non-lesional_pre-dose | 106.7 | 43 |
GSM1296108 | G_non-lesional_pre-dose | 331 | 60 |
GSM1296110 | H_non-lesional_pre-dose | 292.81 | 57 |
GSM1296081 | I_non-lesional_pre-dose | 141.75 | 48 |
GSM1296091 | J_non-lesional_pre-dose | 82.15 | 39 |
GSM1296075 | K_non-lesional_pre-dose | 101.35 | 43 |
GSM1296112 | L_non-lesional_pre-dose | 218.59 | 52 |
GSM1296100 | M_non-lesional_pre-dose | 12.61 | 12 |
GSM1296087 | O_non-lesional_pre-dose | 46.27 | 32 |
GSM1296118 | P_non-lesional_pre-dose | 150.96 | 45 |
GSM1296114 | Q_non-lesional_pre-dose | 525.43 | 68 |
GSM1296097 | R_non-lesional_pre-dose | 55.1 | 33 |
GSM1296106 | S_non-lesional_pre-dose | 47.98 | 29 |
GSM1296102 | U_non-lesional_pre-dose | 61.13 | 33 |
GSM1296122 | V_non-lesional_pre-dose | 98.3 | 39 |
GSM1296089 | W_non-lesional_pre-dose | 133.88 | 45 |
GSM1296083 | X_non-lesional_pre-dose | 90.65 | 40 |
GSM1296116 | Y_non-lesional_pre-dose | 344.97 | 60 |
GSM1296085 | Z_non-lesional_pre-dose | 62.59 | 34 |